Interpreting the price war for generic sotorasib: How do patients benefit?
Sotorasib (Sotorasib) is a cancer drug used to treat adult patients with advanced non-small cell lung cancer (NSCLC) whose cells have specific genetic changes. This change occurs in the gene KRAS and is called "KRAS G12C." Sotorasiib is given when disease has progressed after systemic therapy (treatment that affects the entire body).
The original drug of Sotorasibu has not yet entered the domestic market, so domestic patients can only look forward to the drug and sigh. In Hong Kong, China, a box of 120mg*240 tablets of sotoraxibe costs up to RMB 80,000. Even in Europe, the same specifications cost more than RMB 40,000, and the price fluctuates with the exchange rate, which is undoubtedly a heavy burden for ordinary families.
However, the emergence of generic versions provides some options for patients in need. In some countries, such as Laos, India and other places, some pharmaceutical companies have successfully developed generic drugs of sotorasibu that have basically the same ingredients as the original drug. Not only are the quality of these generic drugs guaranteed, but their prices have also dropped significantly, providing a more affordable treatment option for patients.
Take the Lucius Pharmaceutical Factory in Laos as an example. The generic drug they produce120mg*56 tablets of sotoraxibu is priced at just over 1,000 yuan per box. In comparison, it is undoubtedly a world of difference. Similarly, the price of Daxiong Pharmaceutical's products is more than 2,000 yuan, which is slightly higher but still far lower than the price of the original drug. Such a price allows more patients to see the hope of treatment and allows more families to afford this life-saving medicine.
The emergence of generic sotoracib is not only an economic choice, but also a new hope for treatment. It allows more patients to have similar or even the same therapeutic effect as the original drug without having to bear high financial pressure. This undoubtedly provides more payment methods for patients who are eager for treatment and recovery. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)